Industry News
Health dept suspends clinical director
Dr Bruce Hall, the clinical director in medicine at Liverpool Hospital, has been suspended by the New South Wales Health Department. [ + ]
Venter sets up non-profits for gene ethics, applications
Celera Genomics Group founder Craig Venter has formed three not-for-profit organisations to study the ethics and social implications of genetic technology, and to look for applications of biotechnology in energy production. [ + ]
Genetic manipulation to free Murray-Darling of carp
CSIRO scientists have hatched an ambitious plan to wipe out carp in the Murray-Darling River, by using genetically manipulated carp that lack the ability to change sex. [ + ]
Starpharma STD gel in US tests
The US government is paying for tests of a Melbourne-developed microbicide gel on macaque monkeys. [ + ]
BresaGen to build new research facility
Adelaide-based company BresaGen has received $8.9 million from the South Australian government to build a new research facility at the Thebarton Biotechnology Precinct. [ + ]
Transgenic start-up stalled by grant freeze
A Melbourne start-up looking at pigs as potential organ donors is among hundreds of Australian businesses to be affected by the suspension of the Federal government's R&D Start program. [ + ]
Progen's cancer drug in trials
Brisbane based Progen Industries has moved into Phase II clinical trials for their small molecule cancer drug PI-88. [ + ]
Argus makes artificial cornea
In a major advance for ophthalmology, the Lion's Eye Institute in Perth has developed a flexible, artificial cornea made of hydrogel polymers. [ + ]
Ambri gets new business software
Ambri has adopted new business software and services from Frontstep, to help it to take its new clinical diagnostic system from prototype to full-scale manufacture. [ + ]
Peacock to head Academy of Science
CSIRO Plant Industry chief Dr Jim Peacock has been elected to head the Australian Academy of Science (AAS) after 27 years in the academy. [ + ]
Analytica achieves its first positive cash flow
Analytica has posted its first positive operating cash flow on the back of its takeover by listed medical diagnostics group Psiron last year. [ + ]
Gene responsible for rare body-fat disorder identified
An international team of researchers led by scientists at UT Southwestern Medical Center at Dallas have identified the gene that causes a rare body-fat disorder, a discovery that may ultimately expand the understanding of obesity-related illnesses.
[ + ]Prima technology showing positive results
Prima Biomed's (ASX: PRR) vaccine platform technology has taken another step towards success by triggering a strong immune response in large animals, the company reported today. [ + ]
Wilmut disappointed, others happy with cloning progress
Recent media interviews with Dr Ian Wilmut, the scientist responsible for cloning Dolly the sheep, have suggested that all clones are genetically and physically defective. [ + ]
McGauran promises action on killer jellyfish research
Science Minister Peter McGauran has pledged his support to a call for funding to research the tiny irukandji jellyfish, which has claimed two lives off the Queensland coast this year. [ + ]